Display options
Cite
Molinari C, Battaglia A, Grossini E, et al. The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs. J Physiol. 2003;549:937-44doi: 10.1113/jphysiol.2003.040170.
Molinari, C., Battaglia, A., Grossini, E., Mary, D. A., Vassanelli, C., & Vacca, G. (2003). The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs. The Journal of physiology, 549937-44. https://doi.org/10.1113/jphysiol.2003.040170
Molinari, C, et al. "The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs." The Journal of physiology vol. 549 (2003): 937-44. doi: https://doi.org/10.1113/jphysiol.2003.040170
Molinari C, Battaglia A, Grossini E, Mary DA, Vassanelli C, Vacca G. The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs. J Physiol. 2003 Jun 15;549:937-44. doi: 10.1113/jphysiol.2003.040170. Epub 2003 Apr 17. PMID: 12702737; PMCID: PMC2342994.
Copy Download .nbib Format: NLM
Share it on

J Physiol. 2003 Jun 15;549:937-44. doi: 10.1113/jphysiol.2003.040170. Epub 2003 Apr 17.

The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs.

The Journal of physiology

C Molinari, A Battaglia, E Grossini, D A S G Mary, C Vassanelli, G Vacca

Affiliations

  1. Laboratorio di Fisiologia, Dipartimento di Scienze Mediche, Facoltà di Medicina e Chirurgia, Università del Piemonte Orientale 'A. Avogadro', Novara, Italy. [email protected]

PMID: 12702737 PMCID: PMC2342994 DOI: 10.1113/jphysiol.2003.040170

Abstract

Extensive research suspecting an association between plasma levels of dehydroepiandrosterone and the risk of coronary heart disease has not been conclusive. The present study was designed to investigate the effect of dehydroepiandrosterone on the coronary circulation and to determine the mechanisms involved. In prepubertal pigs of both sexes anaesthetized with sodium pentobarbitone, changes in left circumflex or anterior descending coronary flow caused by intravenous infusion of dehydroepiandrosterone were assessed using an electromagnetic flowmeter. Changes in heart rate and arterial pressure were prevented by atrial pacing and by connecting the arterial system to a pressurized reservoir containing Ringer solution. In 20 pigs, infusion of 1 mg h-1 of dehydroepiandrosterone caused a decrease in coronary flow without affecting left ventricular dP/dtmax (rate of change of left ventricular systolic pressure) and filling pressures of the heart. In a further eight pigs, a dose-response curve was obtained by graded increases in the infused dose of hormone between 0.03 and 4 mg h-1. The mechanisms of the above response were studied in the 20 pigs by repeating the experiment after haemodynamic variables had returned to the control values observed before infusion. Blockade of muscarinic cholinoceptors with intravenous atropine (five pigs) and of alpha-adrenoceptors with intravenous phentolamine (five pigs) did not affect the dehydroepiandrosterone-induced coronary vasoconstriction. This response was abolished by blockade of beta-adrenoceptors with intravenous propranolol (five pigs) and of coronary nitric oxide synthase with intracoronary injection of Nomega-nitro-L-arginine methyl ester (five pigs) even after reversing the increase in arterial pressure and coronary vascular resistance caused by the two blocking agents with intravenous infusion of papaverine. The present study showed that intravenous infusion of dehydroepiandrosterone primarily caused coronary vasoconstriction. The mechanisms of this response were shown to involve the inhibition of a vasodilatory beta-adrenergic receptor-mediated effect related to the release of nitric oxide.

References

  1. Exp Physiol. 1996 May;81(3):385-96 - PubMed
  2. J Physiol. 2002 Aug 15;543(Pt 1):365-72 - PubMed
  3. J Vet Pharmacol Ther. 1981 Sep;4(3):183-91 - PubMed
  4. Physiol Rev. 1983 Jan;63(1):1-205 - PubMed
  5. J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):139-44 - PubMed
  6. Am J Physiol. 1986 May;250(5 Pt 2):H892-7 - PubMed
  7. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  8. J Androl. 1990 Sep-Oct;11(5):460-70 - PubMed
  9. Am J Physiol. 1992 Jan;262(1 Pt 2):H10-6 - PubMed
  10. J Vasc Res. 1992 Jan-Feb;29(1):2-7 - PubMed
  11. FASEB J. 1992 Sep;6(12):3073-5 - PubMed
  12. Circulation. 1992 Nov;86(5):1529-35 - PubMed
  13. Circ Res. 1993 Aug;73(2):241-51 - PubMed
  14. Circulation. 1994 Jan;89(1):89-93 - PubMed
  15. Cardiovasc Res. 1993 Nov;27(11):1920-4 - PubMed
  16. Atherosclerosis. 1994 Feb;105(2):191-200 - PubMed
  17. Circulation. 1995 Mar 15;91(6):1757-60 - PubMed
  18. J Physiol. 1995 Jun 15;485 ( Pt 3):817-25 - PubMed
  19. Hypertension. 1995 Dec;26(6 Pt 2):1065-9 - PubMed
  20. Ann N Y Acad Sci. 1995 Dec 29;774:259-70 - PubMed
  21. Ann N Y Acad Sci. 1995 Dec 29;774:271-80 - PubMed
  22. J Physiol. 1996 Mar 15;491 ( Pt 3):843-51 - PubMed
  23. Atherosclerosis. 1996 Aug 23;125(1):1-13 - PubMed
  24. Circulation. 1996 Nov 1;94(9):2201-9 - PubMed
  25. J Endocrinol. 1996 Sep;150 Suppl:S149-53 - PubMed
  26. Pflugers Arch. 1998 Jul;436(2):159-67 - PubMed
  27. J Physiol. 1999 Feb 1;514 ( Pt 3):875-84 - PubMed
  28. J Clin Epidemiol. 1999 Feb;52(2):95-103 - PubMed
  29. Steroids. 1999 Sep;64(9):640-7 - PubMed
  30. Exp Physiol. 2000 Mar;85(2):203-8 - PubMed
  31. Physiol Res. 2000;49 Suppl 1:S43-56 - PubMed
  32. J Clin Endocrinol Metab. 2000 Sep;85(9):3208-17 - PubMed
  33. Exp Physiol. 2001 Jan;86(1):101-8 - PubMed
  34. J Vasc Res. 2002 Nov-Dec;39(6):504-13 - PubMed

Substances

MeSH terms

Publication Types